JENNIFER GOULDING
Vice President, Finance and FP&A
Jennifer Goulding brings over 20 years of financial, accounting, and operational experience to her role at Atavistik Bio. Most recently, Jennifer was Senior Director of FP&A at Surface Oncology where she was responsible for overseeing the FP&A function until it was acquired by Coherus in 2023. Prior to Surface Oncology, Jennifer held various finance positions at Bioverativ (acquired by Sanofi), Tamr, Infinity Pharmaceuticals, Perkin Elmer and Ernst & Young. Jennifer has a BA from University of California Los Angeles (UCLA) and earned her CPA license in California.